Steven Cohen Cogent Biosciences, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 10,470,398 shares of COGT stock, worth $93.2 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

10,470,398

Previous 10,470,398 -0.0%

Holding current value

$93.2 Million

Previous $88.3 Million 28.11%

% of portfolio

0.31%

Previous 0.24%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 19, 2024	SELL	$6.01 - $9.04 $27.1 Million - $40.8 Million	-4,516,000 Reduced 30.13%	10,470,398 $88.3 Million
Q2 2024 Aug 14, 2024	BUY	$6.01 - $9.04 $49.9 Million - $75.1 Million	8,310,150 Added 124.47%	14,986,398 $126 Million
Q1 2024 May 15, 2024	BUY	$4.38 - $9.02 $6.5 Million - $13.4 Million	1,484,800 Added 28.6%	6,676,248 $44.9 Million
Q4 2023 Feb 14, 2024	BUY	$4.06 - $10.08 $5.78 Million - $14.4 Million	1,424,693 Added 37.82%	5,191,448 $30.5 Million
Q3 2023 Nov 14, 2023	SELL	$9.69 - $13.34 $8.9 Million - $12.3 Million	-918,299 Reduced 19.6%	3,766,755 $36.7 Million
Q2 2023 Aug 14, 2023	BUY	$9.85 - $13.24 $24.1 Million - $32.4 Million	2,448,354 Added 109.46%	4,685,054 $55.5 Million
Q1 2023 May 15, 2023	BUY	$10.04 - $15.5 $22.5 Million - $34.7 Million	2,236,700 New	2,236,700 $24.1 Million
Q3 2022 Nov 14, 2022	BUY	$9.39 - $16.99 $3.35 Million - $6.07 Million	357,200 New	357,200 $5.33 Million
Q2 2022 Aug 15, 2022	SELL	$3.92 - $9.73 $3.35 Million - $8.3 Million	-853,451 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.31 - $8.7 $71,414 - $117,006	-13,449 Reduced 1.55%	853,451 $6.39 Million
Q4 2021 Feb 14, 2022	SELL	$7.51 - $10.81 $1.04 Million - $1.5 Million	-138,403 Reduced 13.77%	866,900 $7.44 Million
Q3 2021 Nov 15, 2021	SELL	$5.99 - $9.14 $2.86 Million - $4.37 Million	-477,792 Reduced 32.22%	1,005,303 $8.46 Million
Q2 2021 Aug 16, 2021	BUY	$7.82 - $9.3 $6.82 Million - $8.11 Million	871,595 Added 142.53%	1,483,095 $12 Million
Q1 2021 May 17, 2021	BUY	$7.47 - $12.34 $1.54 Million - $2.55 Million	206,500 Added 50.99%	611,500 $5.37 Million
Q4 2020 Feb 16, 2021	BUY	$9.04 - $13.01 $3.66 Million - $5.27 Million	405,000 New	405,000 $4.55 Million

Others Institutions Holding COGT

# of Institutions

170

Shares Held

113M

Call Options Held

56.7K

Put Options Held

40.4K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $585M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account